EvaluatePharma forecasts that NVS will be #1 in the world in prescription-drug sales starting in 2014 and will hold the top rank through 2018; PFE and SNY will hold the #2 and #3 slots (or vice-versa) during this period:
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.